--- title: "INVO Fertility, Inc. (IVF.US)" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/IVF.US.md" symbol: "IVF.US" name: "INVO Fertility, Inc." industry: "Health Care Equipment" datetime: "2026-05-20T08:35:12.549Z" locales: - [en](https://longbridge.com/en/quote/IVF.US.md) - [zh-CN](https://longbridge.com/zh-CN/quote/IVF.US.md) - [zh-HK](https://longbridge.com/zh-HK/quote/IVF.US.md) --- # INVO Fertility, Inc. (IVF.US) ## Company Overview INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. It also operates fertility clinics, including INVO Centers. | Item | Detail | |------|--------| | Industry | Health Care Equipment | | Exchange | US Market | | Website | [www.invobioscience.com](https://www.invobioscience.com) | ## Key Drivers > *AI-analyzed key factors driving this stock's performance* ## Longbridge Financial Score™: C > *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge* > Updated: 2026-05-20T04:30:13.000Z **Overall: C (0.55)** **Industry**: Health Care Equipment | Metric | Value | |--------|-------| | Industry Ranking | 116 / 183 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. **Multi Score**: C #### Style Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -11.73% | | | Net Profit YoY | -128.30% | | | P/B Ratio | -0.76 | | | Dividend Ratio | 0.00% | | #### Size Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 2310049.17 | | | Revenue | 6943899.00 | | #### Multi Score Score: C | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 122.69% | A | | Profit Margin | -417.01% | E | | Gross Margin | 35.82% | C | | Revenue YoY | -11.73% | E | | Net Profit YoY | -128.30% | E | | Total Assets YoY | 1101.17% | A | | Net Assets YoY | 140.31% | A | | Cash Flow Margin | 26.22% | D | | OCF YoY | -11.73% | E | | Turnover | 0.68 | B | | Gearing Ratio | 68.94% | D | ```chart-data:radar { "title": "Longbridge Financial Score - INVO Fertility, Inc.", "chart_type": "radar", "dimensions": [ { "name": "Style Score", "grade": "", "indicators": [ { "name": "Revenue YoY", "value": "-11.73%", "rating": "" }, { "name": "Net Profit YoY", "value": "-128.30%", "rating": "" }, { "name": "P/B Ratio", "value": "-0.76", "rating": "" }, { "name": "Dividend Ratio", "value": "0.00%", "rating": "" } ] }, { "name": "Size Score", "grade": "", "indicators": [ { "name": "Market Cap", "value": "2310049.17", "rating": "" }, { "name": "Revenue", "value": "6943899.00", "rating": "" } ] }, { "name": "Multi Score", "grade": "C", "indicators": [ { "name": "ROE", "value": "122.69%", "rating": "A" }, { "name": "Profit Margin", "value": "-417.01%", "rating": "E" }, { "name": "Gross Margin", "value": "35.82%", "rating": "C" }, { "name": "Revenue YoY", "value": "-11.73%", "rating": "E" }, { "name": "Net Profit YoY", "value": "-128.30%", "rating": "E" }, { "name": "Total Assets YoY", "value": "1101.17%", "rating": "A" }, { "name": "Net Assets YoY", "value": "140.31%", "rating": "A" }, { "name": "Cash Flow Margin", "value": "26.22%", "rating": "D" }, { "name": "OCF YoY", "value": "-11.73%", "rating": "E" }, { "name": "Turnover", "value": "0.68", "rating": "B" }, { "name": "Gearing Ratio", "value": "68.94%", "rating": "D" } ] } ] } ``` ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -0.08 | 53/183 | - | - | - | | PB | -0.76 | 154/183 | - | - | - | | PS (TTM) | 0.33 | 9/183 | 0.50 | 0.29 | 0.12 | | Dividend Yield | 0.00% | - | - | - | - | ## Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | | --- | --- | --- | --- | --- | --- | --- | --- | | 01 | Delcath (DCTH.US) | C | A | B | A | A | A | | 02 | Electromed (ELMD.US) | A | B | A | A | B | A | | 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B | | 04 | Stryker (SYK.US) | A | C | C | C | B | B | | 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B | ## Institutional View ### Analyst Rating Distribution > As of 2026-02-10T05:00:00.000Z Total Analysts: **1** | Rating | Count | Percentage | |--------|-------|-----------| | Overweight | 1 | 100% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 1.43 | | Highest Target | 20.00 | | Lowest Target | 20.00 | ## References - [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/IVF.US/overview.md) - [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/IVF.US/norm.md) - [Related News](https://longbridge.com/en/quote/IVF.US/news.md) - [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/IVF.US/filings.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**